Saroja Pharma Industries India Limited
ListedSMEChemicals & Pharmaceuticals · NSE
Saroja Pharma Industries India Limited, incorporated in 2019, is engaged in trading, exporting, and supplying specialty chemicals and APIs. The company deals in three major product categories: chemicals, pharma intermediaries, and veterinary pharma APIs. It supplies products like Liquid Bromine (used as an agro-intermediate), Ethyl Acetate (used as an API solvent), and other pharma-based chemicals used in human and veterinary medicines. APIs or bulk actives are the key ingredients used in producing finished dosage forms like tablets, capsules, and liquids. The company exports its products to international markets including Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore, and more.
Price Band
₹84
Issue Size
₹9.11 Cr
Lot Size
1600 shares
GMP
—
Est. Listing
₹84
at current GMP
Subscribed
8.86x
overall
Open
31 Aug 2023
Close
5 Sep 2023
Allotment
12 Sep 2023
Refund
13 Sep 2023
Demat Credit
14 Sep 2023
Listing
13 Sep 2023
Last updated 12 days ago
Overall Subscription
8.86x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
2.98x
High Net-Worth
Retail (RII)
14.74x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| NIB | 515,200 | 1,536,000 | 2.98x |
| RETAIL | 515,200 | 7,595,200 | 14.74x |
| Total | 1,030,400 | 9,131,200 | 8.86x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 237 | 3,493 | 14.74x |
| HNIs (10L +) | 2 | 6 | 2.98x |
| HNIs (2-10L) | 7 | 21 | 2.98x |
| Total Applications | 246 | 3,520 | 14.31x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Saroja Pharma Industries India Limited Public Issue & Market Profile
Saroja Pharma Industries India Limited is bringing an initial public offering (IPO) in the Chemicals & Pharmaceuticals sector with an aggregate issue size of ₹9.11 Crores. The shares are offered at a price band of ₹84 to ₹84 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Bidding & Quota Instructions:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Allotment Reconciliation Schedule:
Following the close of bidding on 2023-09-05, the basis of allotment is scheduled to be finalized on 2023-09-12. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Saroja Pharma Industries India Limited IPO GMP today?
Currently, Saroja Pharma Industries India Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹84 to ₹84 per equity share.
What is the expected profit per lot for Saroja Pharma Industries India Limited IPO?
The retail lot size is 1600 shares requiring a minimum application amount of ₹1,34,400. Expected listing price is ₹84 per equity share.
What is the issue size and price band for Saroja Pharma Industries India Limited IPO?
The Saroja Pharma Industries India Limited IPO aggregate issue size is ₹9.11 Crores with an equity price band set at ₹84 to ₹84 per equity share. The retail lot size is 1600 shares requiring a minimum capital outlay of approx. ₹1,34,400.
How can I check Saroja Pharma Industries India Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 8.86x (Retail: 14.74x, QIB: 0.00x, NII: 2.98x). You can track live multiples directly on our dedicated subscription page.
Where and when will Saroja Pharma Industries India Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2023-09-12. Investors can verify status using PAN card or application number.
When is the listing date for Saroja Pharma Industries India Limited IPO?
Saroja Pharma Industries India Limited shares are scheduled to list on NSE on 2023-09-13.